Literature DB >> 18292347

The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing.

Maziyar Saberi1, MaryAnn Bohland, Casey M Donovan.   

Abstract

OBJECTIVE: To ascertain whether portal glucose sensing extends beyond the portal vein to the superior mesenteric vein and then test whether the role of portal-superior mesenteric glucose sensors varies with the rate of fall in glycemia. RESEARCH DESIGN AND METHODS: Chronically cannulated rats underwent afferent ablation of the portal vein (PV) or portal and superior mesenteric veins (PMV) or sham operation (control). One week later, animals underwent hyperinsulinemic-hypoglycemic clamps in which the hypoglycemic nadir, 2.48 +/- 0.06 mmol/l, was reached at a rate of decline in glucose of -0.09 or -0.21 mmol x l(-1) x min(-1) (PMV and control only). Additional PMV and control animals received an intravenous injection of the glucopenic agent 2-deoxyglucose. RESULTS; Inducing hypoglycemia slowly, at a rate of -0.09 mmol x l(-1) x min(-1), resulted in a 26-fold increase in epinephrine (23.39 +/- 0.62 nmol/l) and 12-fold increase in norepinephrine (11.42 +/- 0.92 nmol/l) for controls (P < 0.001). The epinephrine response to hypoglycemia was suppressed by 91% in PMV (2.09 +/- 0.07 nmol/l) vs. 61% in PV (9.05 +/- 1.59 nmol/l) (P < 0.001). The norepinephrine response to hypoglycemia was suppressed by 94 and 80% in PMV and PV, respectively, compared with that in controls. In contrast, when arterial glucose was lowered to 2.49 +/- 0.06 mmol/l within 20 min, no significant differences were observed in the catecholamine responses for PMV and controls over the first 45 min of hypoglycemia (20-65 min). Only at min 105 were catecholamines significantly lower for PMV vs. controls. Injection of 2-deoxyglucose induced a very rapid sympathoadrenal response with no significant differences between PMV and controls.
CONCLUSIONS: The critical locus for hypoglycemic detection shifts away from the portal-mesenteric vein to some other loci (e.g., the brain) when hypoglycemia develops rapidly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292347     DOI: 10.2337/db07-1528

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

1.  Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus.

Authors:  Meredith B Barnes; Marcus A Lawson; J Lee Beverly
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

2.  The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing.

Authors:  Fabien Delaere; Adeline Duchampt; Lourdes Mounien; Pascal Seyer; Céline Duraffourd; Carine Zitoun; Bernard Thorens; Gilles Mithieux
Journal:  Mol Metab       Date:  2012-12-07       Impact factor: 7.422

Review 3.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

Review 4.  Minireview: The value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit.

Authors:  Sue Ritter; Ai-Jun Li; Qing Wang; Thu T Dinh
Journal:  Endocrinology       Date:  2011-08-30       Impact factor: 4.736

5.  Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

Authors:  Jason J Winnick; Guillaume Kraft; Justin M Gregory; Dale S Edgerton; Phillip Williams; Ian A Hajizadeh; Maahum Z Kamal; Marta Smith; Ben Farmer; Melanie Scott; Doss Neal; E Patrick Donahue; Eric Allen; Alan D Cherrington
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

Review 6.  Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation.

Authors:  Alan G Watts; Casey M Donovan
Journal:  Front Neuroendocrinol       Date:  2009-10-24       Impact factor: 8.606

7.  Glucose sensing during hypoglycemia: lessons from the lab.

Authors:  Rory McCrimmon
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 17.152

8.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

9.  Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure.

Authors:  Lina Sabra-Makke; Micol Maritan; Julien Planchais; Marie Boutant; Jean-Paul Pégorier; Patrick C Even; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

10.  Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.

Authors:  Xavier Fioramonti; Nicolas Marsollier; Zhentao Song; Kurt A Fakira; Reema M Patel; Stacey Brown; Thibaut Duparc; Arnaldo Pica-Mendez; Nicole M Sanders; Claude Knauf; Philippe Valet; Rory J McCrimmon; Annie Beuve; Christophe Magnan; Vanessa H Routh
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.